Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Ringold

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Pediatric Rheumatology Online Journal|December 18, 2019
Oral health and plaque microbial profile in juvenile idiopathic arthritisSriharsha Grevich, Peggy Lee, Brian Leroux, et al.
The Journal of Rheumatology|January 17, 2017
Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research StudiesPeter Stoustrup, Marinka Twilt, Lynn Spiegel, et al.
BMJ Open|January 27, 2023
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluationElissa R Weitzman, Amy Gaultney, Emily von Scheven, et al.
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.
The Journal of Rheumatology|April 3, 2020
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry StudyKuan Liu, George Tomlinson, Ann M Reed, et al.
Pediatric Rheumatology Online Journal|April 13, 2017
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment PlansYukiko Kimura, Sriharsha Grevich, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 28, 2021
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic ArthritisChiara Trincianti, Evert Hendrik Pieter Van Dijkhuizen, Alessandra Alongi, et al.
Arthritis and Rheumatism|December 21, 2011
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritisCarol A Wallace, Edward H Giannini, Steven J Spalding, et al.
The Journal of Rheumatology|May 3, 2014
Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictorsCarol A Wallace, Edward H Giannini, Steven J Spalding, et al.
The Journal of Rheumatology|August 17, 2017
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Esi M Morgan, Meredith P Riebschleger, Jennifer Horonjeff, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Pediatric Rheumatology Online Journal|December 18, 2019
Oral health and plaque microbial profile in juvenile idiopathic arthritisSriharsha Grevich, Peggy Lee, Brian Leroux, et al.
The Journal of Rheumatology|January 17, 2017
Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research StudiesPeter Stoustrup, Marinka Twilt, Lynn Spiegel, et al.
BMJ Open|January 27, 2023
Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluationElissa R Weitzman, Amy Gaultney, Emily von Scheven, et al.
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.
The Journal of Rheumatology|April 3, 2020
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry StudyKuan Liu, George Tomlinson, Ann M Reed, et al.
Pediatric Rheumatology Online Journal|April 13, 2017
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment PlansYukiko Kimura, Sriharsha Grevich, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 28, 2021
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic ArthritisChiara Trincianti, Evert Hendrik Pieter Van Dijkhuizen, Alessandra Alongi, et al.
Arthritis and Rheumatism|December 21, 2011
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritisCarol A Wallace, Edward H Giannini, Steven J Spalding, et al.
The Journal of Rheumatology|May 3, 2014
Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictorsCarol A Wallace, Edward H Giannini, Steven J Spalding, et al.
The Journal of Rheumatology|August 17, 2017
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Esi M Morgan, Meredith P Riebschleger, Jennifer Horonjeff, et al.
Pageof 11